Viewing Study NCT03872232

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:45 PM

Ignite Modification Date: 2026-02-23 @ 5:51 AM

Study NCT ID: NCT03872232

Status: COMPLETED

Last Update Posted: 2021-01-15

First Post: 2019-03-11

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

Sponsor: Addpharma Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module